Higher serum alkaline phosphatase activity in infants born to vitamin D-deficient mothers

Ibrahim Al Alwan1,2,3, Maryam Al Badi4,5, Motasim Badri4,6

  • 1King Abdullah Specialized Children's Hospital, Ministry of National Guard Health Affairs, Po Box 3600, Riyadh, 11481, Saudi Arabia. alwani@ksau-hs.edu.sa.

Archives of Osteoporosis
|October 26, 2019
PubMed

Insights

Maternal vitamin D deficiency is common and linked to higher newborn alkaline phosphatase (ALP) activity, suggesting increased bone turnover and potential impacts on fetal skeletal development.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Endocrinology

Background:

  • Low maternal 25-hydroxy vitamin D (25(OH)D) during pregnancy can lead to infant vitamin D deficiency at birth.
  • This deficiency poses risks to fetal skeletal mineralization and growth.
  • Alkaline phosphatase (ALP) activity is a marker of bone turnover.

Purpose of the Study:

  • To investigate the relationship between maternal serum 25(OH)D levels and newborn serum ALP activity at term.
  • To assess the impact of maternal vitamin D status on fetal bone metabolism.

Main Methods:

  • Prospective cross-sectional study involving 150 healthy pregnant mothers and their newborns.
  • Maternal serum 25(OH)D levels measured within 6 hours of delivery.
  • Newborn cord blood analyzed for calcium, phosphorus, and ALP activity.

Main Results:

  • 72% of mothers were vitamin D-deficient (25(OH)D < 25 nmol/l).
  • Newborns of vitamin D-deficient mothers exhibited significantly higher ALP activity (p=0.04).
  • A significant inverse correlation was found between maternal 25(OH)D levels and infant ALP activity (p=0.03).

Conclusions:

  • Newborns of vitamin D-deficient mothers show elevated ALP activity, indicative of increased bone turnover.
  • This finding suggests a potential negative impact on fetal bone development and skeletal growth.
  • Maternal vitamin D status is a critical factor in fetal skeletal health.

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.4K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
4.9K
Introduction to Electrolytes01:33

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
15.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
160